Loop-mediated Isothermal Amplification (LAMP) Market size was valued at USD 123.01 million in 2024 and is expected to reach USD 256.01 million by 2037, expanding at around 5.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of loop-mediated isothermal amplification is assessed at USD 134.69 million.
The growth of the market can be attributed to the increasing number of chronic diseases among the population around the world. Further, the growing prevalence of illnesses such as diabetes, cardiovascular and respiratory diseases, cancer, and others, owing to the consumption of unhealthy foods, and rising stress levels among people are also expected to increase the utilization rate of loop-mediated isothermal amplification (LAMP) in the assessment period. It was found during research that more than 19.8% of India’s population suffers from at least one chronic illness, and nearly 10.1% of persons have multiple chronic illnesses.
Apart from the aforementioned factors, the market growth is also attributed to the rising need for the detection of pathogens in patient samples owing to the increasing cases of infection across the globe. Tuberculosis, hepatitis, and influenza are some of the infectious diseases that are responsible for taking millions of lives every year. Thus, the advantages of loop-mediated isothermal amplification, including disease-specific testing options, have made it a preferred option in various clinical and industrial settings. It was noted that at least 2 million Americans contract an infection that is unable to be treated each year, and at least 23,000 of them pass away.
Growth Drivers
Increasing Investment in Research and Development – It was noticed that global research and development spending has more than tripled in real terms since 2000, rising from USD 677 billion to USD 2.2 trillion in 2019. The market is estimated to gain a significant boost over the forecast period owing to increasing investment in the R&D sector of the pharmaceutical industry. Along with that, the high expenditure made in the field of the healthcare sector is supporting laboratory tests to provide quick and more accurate results, which are anticipated to bring growth opportunities for the market in the upcoming years.
Rising Expenditure in the Healthcare Sector – With the high prevalence of diseases around the world, people everywhere are propelled to spend more money on diagnostics and treatment processes that are forecasted to increase the utilization rate of loop-mediated isothermal amplification. Moreover, the recent government investment in the healthcare sector is also anticipated to bring new chances for market expansion in the future. As per the World Health Organization, global health spending has increased overall during the previous 20 years, doubling in real terms, reaching USD 8.5 trillion in 2019 and 9.8% of GDP up, from 8.5 percent in 2000.
Growing Prevalence of Pandemic Diseases – On October 19, 2022, the WHO received reports of 623,000,396 confirmed cases of COVID-19 worldwide, including 6,550,033 fatalities.
Rising Malaria Infection - Globally, there were presumably 241 million cases of malaria in 2020, and 627 000 deaths from malaria were estimated in 2020.
High Investment in Technological Advancement –Before the pandemic, investments in innovation were at an all-time high. In 2019, R&D grew at an unprecedented rate of 8.5 percent in the United States. Moreover, Switzerland, Sweden, the U.S., and the U.K. are still at the top of the list for innovation and have been for the previous three years.
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.8% |
|
Base Year Market Size (2024) |
USD 123.01 million |
|
Forecast Year Market Size (2037) |
USD 256.01 million |
|
Regional Scope |
|
End-user (Hospital Laboratories, Research, Academic Institutes, Diagnostic Centers)
The global loop-mediated isothermal amplification (LAMP) market is segmented and analyzed for demand and supply by end-user in hospital laboratories, research and academic institutes, and diagnostic centers. Out of these, the hospital laboratories segment is estimated to gain the largest market share by the end of 2037 owing to the high spending by patients to receive test results from reputable laboratories and their association with blood banks, hospitals, and specialist diagnostic centers. It is believed that by 2024, the medical and diagnostic laboratories of hospitals in the United States are estimated to generate around USD 54 billion in revenue. In addition to this, the release of precise and cutting-edge devices, including companion diagnostics, biochips, microarrays, and other technological advancements in the laboratories segment, is estimated to drive the segment growth over the forecast period.
Application (Diagnostic, Research Purposes)
The global loop-mediated isothermal amplification (LAMP) market is also segmented and analyzed for demand and supply by application for diagnostic and research purposes. Out of these two segments, the diagnostics segment is expected to garner the highest segment share owing to the rising need for diagnosing diseases among the population. The sudden shift towards unhealthy lifestyles and the consumption of deleterious food items is generating illnesses and infections that need to be diagnosed and treated. As a result, the demand for loop-mediated isothermal amplification is forecast to increase in the upcoming few years.
Our in-depth analysis of the global market includes the following segments:
|
By Technology |
|
|
By Application |
|
|
By End User |
|
North American Market Forecast
The North American loop-mediated isothermal amplification (LAMP) market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the increasing frequency of people being diagnosed with chronic diseases generating the need for loop-mediated isothermal amplification as a point-of-care genetic testing for treatment purposes. Recent statistics revealed that in the USA, 4 in 10 adults have two or more chronic diseases, and 6 in 10 have at least one chronic disease. Further, the high prevalence of infectious diseases among Americans is also expected to bring lucrative opportunities for using loop-mediated isothermal amplification for diagnosing and market expansion in the forecast period. Apart from these, the other contributing factor to the market’s growth is the presence of a strong healthcare network along with the major key players in the region. Moreover, the large pool of patients and their high expenditure on the healthcare sector, along with favorable policies, are also anticipated to contribute to the market’s growth in the region. In addition, the region's expanding investment to develop technologically advanced healthcare products and in the research and development (R&D) sector is also anticipated to boost market growth during the forecast period.
Thermo Fisher Scientific
Thermo Fisher Scientific - unveiled the Gibco CTS DynaCellect Magnetic Separation System (DynaCellect), which will make it simpler for companies developing cell therapies to transition from process and clinical development to commercial manufacturing.
HiberGene Diagnostics - announced that it will serve healthcare providers in the UK and Ireland with its cutting-edge point-of-care (POC) and near-patient testing solutions. These top-notch testing options include a range of infectious and communicable disease areas
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?